JMP Securities analyst Jonathan Wolleben initiated coverage of Astria Therapeutics (ATXS) with an Outperform rating and $26 price target ...

JMP Securities initiated coverage of KalVista (KALV) with an Outperform rating and $19 price target KalVista is developing sebetralstat, a ...

JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...

JMP Securities reiterated its Market Outperform rating on BioCryst Pharmaceuticals (NASDAQ:BCRX) with a consistent price target of $18.00. The firm's analysis is based on the performance and market ...

Alexandria Real Estate Equities (NYSE:ARE – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by equities researchers at JMP Securities in a report released on Wednesday,Benzinga ...

AI is evolving rapidly with recent breakthroughs making it more accessible and efficient than ever. Smaller, cost-effective ...

The web services and cybersecurity specialist's share price ended the day's trading up 10.7% amid the backdrop of a 0.8% gain ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...

This article focuses on the latest stock ratings and analyst calls on AI companies involved in digital advertising, drone ...

Investing.com -- JMP Securities initiated coverage on digital infrastructure companies on AI related spending boom. Over the next five years, over $1 trillion in investments is expected, driven by AI, ...